COSMOS HEALTH INC (COSM)

US2214133058 - Common Stock

0.6901  +0.02 (+3.15%)

COSMOS HEALTH INC

NASDAQ:COSM (1/2/2025, 1:03:54 PM)

0.6901

+0.02 (+3.15%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustryHealth Care Distributors
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-70.16%
Sales Q2Q%-3.22%
CRS10.2
6 Month-37.48%
Overview
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Ins Owners8.99%
Inst Owners3.33%
Market Cap16.11M
Shares23.35M
PEN/A
Fwd PE67.66
Dividend YieldN/A
Analysts82.86
Short Float %1.78%
Short Ratio1.41
IPO05-19 2010-05-19
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

COSM Daily chart

Company Profile

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois and currently employs 123 full-time employees. The company went IPO on 2010-05-19. The firm owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. The company offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. The company is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.

Company Info

COSMOS HEALTH INC

141 W. Jackson Blvd, Suite 4236

Chicago ILLINOIS

P: 13125363102

Employees: 123

Website: https://www.cosmosholdingsinc.com/